EUVIMEDEUVIMED entdecken
Crossref

Network pharmacology, molecular docking, molecular dynamics simulation, and in vivo experiments elucidate the potential mechanisms of berberine against liver injury

Lun Zhang, Lijuan Cheng, Qianqian Huang, Yun Yu

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04697-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Lun Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, 230012, China. Hauptthemen laut MEDLINE: Berberine, Chemical and Drug Induced Liver Injury, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Berberine (BBR), a compound extracted from Coptis chinensis Franch, has been used in traditional Chinese medicine to treat liver diseases due to its anti-inflammatory, antioxidant, and liver-protective properties. To explore its therapeutic effects and underlying mechanisms in CCl4-induced liver injury, BBR-related targets were identified using GeneCards, TCMSP, PharmMapper, SwissTargetPrediction, and STITCH, while liver injury-related targets were collected from DisGeNET, GeneCards, TTD, and OMIM. GO and KEGG enrichment analyses were performed via DAVID, and molecular docking along with molecular dynamics simulations revealed strong, stable binding of BBR to TP53, STAT3, EGFR, IL6, CASP3, TNF, and IL-1β. These core targets were mainly enriched in TNF and p53 signaling pathways. A CCl4-induced mouse liver injury model was used for in vivo validation, showing that BBR significantly reduced liver injury markers, improved histopathological changes, and downregulated expression of target genes. Together, these findings suggest that BBR alleviates liver injury by modulating inflammation and apoptosis through the TNF and p53 pathways, providing new insights into its hepatoprotective mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineChemical and Drug Induced Liver InjuryAnti-Inflammatory AgentsAnimalsMolecular Docking SimulationNetwork PharmacologyMolecular Dynamics SimulationMiceMaleCarbon TetrachlorideLiverMice, Inbred C57BLDisease Models, AnimalSignal Transduction

Stichwörter der Autor:innen

BerberineLiver injuryMolecular dynamics simulationMolecular mechanismNetwork pharmacology

Substanzen

BerberineCarbon TetrachlorideAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, 230012, China.
  • Anhui Public Health Clinical Center, Hefei, 230012, China.
  • Department of Pharmacy, Anhui No.2 Provincial People's Hospital, Hefei, 230012, China.
  • Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, 230012, China. 1138446546@qq.com.
  • Anhui Public Health Clinical Center, Hefei, 230012, China. 1138446546@qq.com.
  • Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, 230012, China. 15056920257@163.com.

Zitieren

APA

Zhang, L., Cheng, L., Huang, Q., & Yu, Y. (2026). Network pharmacology, molecular docking, molecular dynamics simulation, and in vivo experiments elucidate the potential mechanisms of berberine against liver injury. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04697-5

Vancouver

Zhang L, Cheng L, Huang Q, Yu Y. Network pharmacology, molecular docking, molecular dynamics simulation, and in vivo experiments elucidate the potential mechanisms of berberine against liver injury. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04697-5

BibTeX
@article{Zhang2026,
  author = {Zhang, Lun and Cheng, Lijuan and Huang, Qianqian and Yu, Yun},
  title = {Network pharmacology, molecular docking, molecular dynamics simulation, and in vivo experiments elucidate the potential mechanisms of berberine against liver injury},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04697-5}
}
Kostenlos starten →